Insight and risk of suicidal behaviour in two first-episode psychosis cohorts: effects of previous suicide attempts and depression by Lopez-Morinigo, Javier-David et al.
                             Elsevier Editorial System(tm) for 
Schizophrenia Research 
                                  Manuscript Draft 
 
 
Manuscript Number: SCHRES-D-18-00516R1 
 
Title: Insight and risk of suicidal behaviour in two first-episode 
psychosis cohorts: effects of previous suicide attempts and depression
  
 
Article Type: Full Length Article 
 
Keywords: Insight; suicidal behaviour risk; first-episode psychosis; 
depression 
 
Corresponding Author: Dr. Javier-David Lopez-Morinigo, MBBS PhD 
 
Corresponding Author's Institution: Department of Psychosis Studies. 
Institute of Psychiatry, Psychology and Neuroscience. King's College 
London 
 
First Author: Javier-David Lopez-Morinigo, MBBS PhD 
 
Order of Authors: Javier-David Lopez-Morinigo, MBBS PhD; Marta Di Forti, 
MBBS PhD; Olesja Ajnakina, PhD; Benjamin DR Wiffen, PhD; Kevin Morgan, 
PhD; Gillian A  Doody, BSc MD MRPsych MSc MPhil MMedSci; Peter B Jones, 
FMedSci, Professor of Psychiatry; Rosa Ayesa-Arriola, PhD; Manuel Canal-
Rivero, MSc PhD; Benedicto Crespo-Facorro, MBBS PhD; Robin M Murray, FRS; 
Paola Dazzan, MD  MSc PhD FRCPsych; Craig Morgan; Rina Dutta, MBBS PhD; 
Anthony S David, MD MSc FRCPsych 
 
Abstract: Background:  
The role of insight dimensions - illness recognition (IR), symptoms 
relabelling (SR), treatment compliance (TC) - in suicide risk in first-
episode psychosis (FEP) remains unclear. 
Method: 
The AESOP (n=181) and GAP (n=112) FEP cohorts were followed-up over 10- 
and 5 years. Survival analysis modelled time to first suicidal event in 
relation to baseline scores on the Schedule for the Assessment of 
Insight, whilst adjusting for demographic, clinical, psychopathological 
and neuropsychological variables. 
Results: 
AESOP: those with previous suicide attempts scored higher on IR (7.6±1.9 
vs. 5.9±3.0, p<0.01) and total insight scores (TIS) (17.2±5.0 vs. 
13.4±6.7, p=0.03). IR (r=0.23, p<0.01), SR (r=0.18, p=0.04) and TC 
(r=0.26, p<0.01) correlated with depression. Univariable analyses: IR 
(HR=1.14, 95%CI=0.98-1.34, p=0.09), TC (HR=1.30, 95%CI=0.99-1.71, p=0.06) 
and TIS (HR=1.06, 95%CI=0.99-1.13, p=0.08) were linked with suicidal 
behaviour. Multivariable regression models: depression (HR=1.55, 
95%CI=1.22-1.97, p<0.01) predicted suicidal behaviour. 
GAP: SR (6.4±3.1 vs. 4.5±3.4, p=0.03) and TIS (16.8±6.4 vs. 12.8±7.4, 
p=0.03) were higher in those with suicidal antecedents. IR (r=0.32, 
p<0.01) and SR (r=0.27, p=0.01) correlated with depression. Univariable 
analyses: TC (HR=1.36, 95%CI=1.01-1.83, p=0.04) and TIS (HR=1.06, 
95%CI=0.99-1.14, p=0.08) were associated with suicidal behaviour. 
Multivariable regression models: previous suicide attempts (HR 5.17, 
95%CI 1.32-20.29, p=0.02) and depression (HR 1.16, 95%CI=1.00-1.35, 
p=0.04) predicted suicidal behaviour. 
Conclusions: 
Suicide attempts prior to FEP and depression at that point were 
associated with baseline insight levels and predicted risk of suicidal 
behaviour over the follow-up, which was not linked with insight. This may 
explain the apparent association of insight with suicidality in FEP. 
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14th August 2018 
 
Dear Editor, 
 
Thank you for your email of 04/07/2018 regarding our submission to 
Schizophrenia Research: ‘SCHRES-D-18-00516 - Insight and risk of suicidal 
behaviour in two first-episode psychosis cohorts: effects of previous suicide attempts 
and depression’.  
Firstly, we much appreciate your consideration for the publication of our 
manuscript in Schizophrenia Research.  
In response to the reviewers’ comments we have introduced the relevant 
changes in the revised manuscript (using yellow highlighting) and we would like to 
make the following clarifications: 
 
Reviewer 1: 
First, reviewer 1 suggested that the caption "total" insight may be substituted 
with some other expression such as ‘global insight’ or ‘total insight scores’. 
Accordingly, we have removed the term ‘total insight’ from the manuscript and we 
have used ‘total insight scores’ (and TIS) in the revised manuscript. 
Second, the reviewer raised issues about ‘reporting R values in the abstract 
unless the measure of depression has been pre-specified explicitly’.  We would 
suggest, however, that the R values do give the reader relevant information on the 
strength of the association between different variables, including insight and 
depression. We have been more explicit in our definition of this, i.e., the 
psychopathological variables scores ranges, including depression, in section 2.2.4. 
(page 6) of the revised manuscript. 
Third, regarding methods, reviewer 1 made three points. Firstly, the reviewer 
requested further clarifications on the definition of suicidal behavior: they 
commented on the importance of the relationship between suicide attempt and 
Nonsuicidal Self-Injury and Suicidal Behavior, including a reference (Grandclerc et 
al. PLoS One. 2016; 11(4): e0153760.). We have clarified this further in the revised 
manuscript (section 2.2.2., page 5) since both AESOP and GAP projects defined 
‘suicidal behaviour’ based on the same criteria (O’Carroll et al., 1996). Second, 
reviewer 1 raised concerns about the potential inclusion of patients with non-
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psychotic disorders. Accordingly, we have amended section 2.1. (page 5, first 
paragraph) in order to further clarify that the diagnosis of ‘psychosis’ was made at 
the study inception, which may have, indeed, resulted in the inclusion of patients 
with non-psychotic diagnoses, which is now reported in the Strengths and 
Limitations section (section 4.5., page 15). Third, reviewer 1 questioned whether we 
had analysed the relationship between suicide methods and lethality. Thankfully, the 
‘low’ number of suicides in both cohorts did not allow us to conduct this analysis 
due to insufficient statistical power, although we have reported this in the limitations 
section of the revised manuscript (section 4.5., last paragraph, page 15).  
Fourth, the reviewer asked whether there were important differences 
between subjects who were retained in the analyses vs. those lost to follow up. As 
pointed to by the reviewer, there is no space left for additional columns in the tables. 
However, we have conducted these analyses and we have found no relevant 
between-groups differences, which is summarised in the last paragraph of section 
3.2. (page 8) of the revised manuscript. Also, we have discussed this further in the 
‘strengths and limitations’ section (first paragraph of section 4.5. of the revised 
manuscript, page 15).  
Fifth, reviewer 1 suggested that a model with insight but without depression 
may yield different results, which, if so, may suggest a mediating role of depression, 
rather than a confounding one. We have conducted these analyses and we have 
replicated our previous findings (despite removing depression from the analyses) 
that insight scores were not associated with time to first suicidal event, which is now 
reported in the revised manuscript (see section 3.3., last paragraph, page 9).  
Sixth, reviewer 1 asked whether insight became a significant predictor of 
suicidal behavior after excluding those subjects with previous suicide attempts. We 
have carried out these analyses, which again revealed that insight was not a risk 
factor for suicidal behaviour. This is now included in the revised manuscript (see 
section 3.3., last paragraph, page 9). 
On the basis of the latter two reviewer’s comments and our findings from the 
analyses, which deserve some comment, we have amended the discussion (see last 
paragraph of section 4.6. on page 15). 
Seventh, reviewer 1 cited a recent meta-analysis ((Pompili et al. Psychol Med. 
2016 Aug;46(11):2239-53)) in order to suggest that those with higher levels of insight 
may be more prone to report previous suicidal events. We totally agree with the 
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reviewer’s point. In our first manuscript we had mentioned that, based on our 
previous systematic review (Lopez-Morinigo et al., 2012), recall bias may contribute 
to the mixed results regarding the association between insight and suicide risk, i.e., 
insightful patients are more likely to recall previous suicidal events. This point is 
expanded in the revised manuscript (second paragraph of section 4.2., pages 10-11).  
Eighth, in order to provide further detail for section 4.2. of the discussion, 
reviewer 1 cited a recent review (Lysaker et al., World Psychiatry. 2018 Feb;17(1):12-
23. doi: 10.1002/wps.20508.) and made a point on the extent to which our findings go 
against the demoralization syndrome, particularly in terms of clinical implications 
for the management of insight from a suicide prevention perspective; for instance, if 
some specific interventions were demonstrated to improve insight while reducing 
suicide risk. We have acted upon the reviewer’s suggestion to expand the discussion 
accordingly in the revised manuscript (see section 4.2., page 11).  
Ninth, reviewer 1 argued that both state and trait-like properties of 
depression in schizophrenia have been observed, which was also supported by a 
reference (Chiappelli et al., Schizophr Bull. 2014 Jan; 40(1): 132-142.), which, although 
included in the first manuscript, has been discussed further in the revised 
manuscript (last paragraph of section 4.4., page 14). 
Finally, reviewer 1 made a point on the causal pathways linking insight with 
suicidal behavior, which could be rather different between subjects with different 
diagnoses, compliance with treatment and socio-cultural aspects (see Belvederi 
Murri Schizophr Bull. 2018 Jun 23. doi: 10.1093/schbul/sby092). Unfortunately, 
either the study was underpowered to test this (for example, differences across 
diagnoses) or we did not collect data on the mentioned variables (e.g. cultural 
aspects). Accordingly, we have reported this limitation in the revised manuscript 
(section 4.5., page 15). 
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Reviewer 2: 
 First, the reviewer suggested that it may be better to describe the complete 
names for two FEP cohorts. Owing to the limited word count, we have had to use 
abbreviations from early in the manuscript, although both samples, and their names, 
are detailed in section 2.1. of the revised manuscript (page 5).  
Second, reviewer 2 stated that ‘the introduction was nicely done’ and the 
reviewer suggested no corrections for this section. 
Third, reviewer 2 suggested beginning the discussion with authors' 
hypotheses (as documented at the end of introduction) rather than first discussing 
conclusions which were not based on their hypotheses. Accordingly, we have 
reworded the first paragraph of the discussion of the revised manuscript (section 
4.1., page 10). In keeping with this, reviewer 2 asked that we reword the paragraph 
"Based on the results from two large FEP cohorts who were followed-up over  … we 
found no evidence of a 'direct' link between insight and suicidality in early 
psychosis", and this has been amended in the revised manuscript (section 4.1., page 
11).  
Fourth, the reviewer asked for further discussion on the relationship between 
adherence to treatment and increased risk of suicidal behavior since this was 
unexpected. We have made this amendment accordingly (see last paragraph of 
section 4.2. on page 11). 
Finally, reviewer 2 suggested expanding the discussion about the different 
possible pathways linking insight, depression and suicidality, which we have done 
in the revised manuscript (see last paragraph of section 4.4. on page 14).  
We have therefore attached our revised manuscript for consideration for 
publication in Schizophrenia Research, including all the amendments based on 
reviewers’ comments in the aforementioned email of 04/07/2018.  
Thank you very much for considering our resubmission for publication and 
we look forward to hearing from you in due course. 
 
Yours sincerely, 
 
Dr Lopez-Morinigo, on behalf of all the authors 
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ABSTRACT  
Background:  
The role of insight dimensions – illness recognition (IR), symptoms relabelling (SR), 
treatment compliance (TC) - in suicide risk in first-episode psychosis (FEP) remains unclear. 
Method: 
The AESOP (n=181) and GAP (n=112) FEP cohorts were followed-up over 10- and 5 
years. Survival analysis modelled time to first suicidal event in relation to baseline scores on 
the Schedule for the Assessment of Insight, whilst adjusting for demographic, clinical, 
psychopathological and neuropsychological variables. 
Results: 
AESOP: those with previous suicide attempts scored higher on IR (7.6±1.9 vs. 5.9±3.0, 
p<0.01) and total insight scores (TIS) (17.2±5.0 vs. 13.4±6.7, p=0.03). IR (r=0.23, p<0.01), SR 
(r=0.18, p=0.04) and TC (r=0.26, p<0.01) correlated with depression. Univariable analyses: IR 
(HR=1.14, 95%CI=0.98-1.34, p=0.09), TC (HR=1.30, 95%CI=0.99-1.71, p=0.06) and TIS 
(HR=1.06, 95%CI=0.99-1.13, p=0.08) were linked with suicidal behaviour. Multivariable 
regression models: depression (HR=1.55, 95%CI=1.22-1.97, p<0.01) predicted suicidal 
behaviour. 
GAP: SR (6.4±3.1 vs. 4.5±3.4, p=0.03) and TIS (16.8±6.4 vs. 12.8±7.4, p=0.03) were 
higher in those with suicidal antecedents. IR (r=0.32, p<0.01) and SR (r=0.27, p=0.01) 
correlated with depression. Univariable analyses: TC (HR=1.36, 95%CI=1.01-1.83, p=0.04) 
and TIS (HR=1.06, 95%CI=0.99-1.14, p=0.08) were associated with suicidal behaviour. 
Multivariable regression models: previous suicide attempts (HR 5.17, 95%CI 1.32-20.29, 
p=0.02) and depression (HR 1.16, 95%CI=1.00-1.35, p=0.04) predicted suicidal behaviour. 
Conclusions: 
Suicide attempts prior to FEP and depression at that point were associated with 
baseline insight levels and predicted risk of suicidal behaviour over the follow-up, which 
was not linked with insight. This may explain the apparent association of insight with 
suicidality in FEP. 
 
Key words: insight, suicidal behaviour risk, first-episode psychosis, depression. 
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1. INTRODUCTION 
Suicide represents a major contributor to the excess mortality in schizophrenia 
(Brown, 1997; Saha et al., 2007), with a lifetime suicide rate currently estimated at 
approximately 5% (Palmer et al., 2005). Between 20% (Lopez-Morinigo et al., 2016) and 40% 
of patients receiving mental healthcare who take their lives have a psychotic disorder 
(Lopez-Morinigo et al., 2018). The risk is particularly higher in first-episode of psychosis 
(FEP) (Melle et al., 2006; Dutta et al., 2010; Dutta et al., 2012; Palmer et al., 2005; Ayesa-
Arriola et al., 2015). A previous meta-analysis revealed previous depression and suicide 
attempts, drugs misuse, agitation or motor restlessness, fear of mental disintegration and 
poor medication compliance to be the most relevant suicide risk factors in schizophrenia 
(Hawton et al., 2005). Interestingly, this meta-analysis found a two-fold increased odds of 
suicide among those with good insight, albeit the number of studies (5) and total number of 
subjects (N=436) were small and the estimate consequently imprecise (OR=2.04, 95%CI 0.54-
7.74); this noted, the OR is consistent with a later meta-analysis of FEP studies (Challis et al., 
2013) showing a modest relationship between insight and suicide risk (OR=1.64, 95%CI 1.23-
2.56). 
Insight in psychosis had not received much attention until it was proposed that it 
comprised three different, albeit overlapping dimensions – (i) illness recognition, (ii) 
symptoms relabelling, and (iii) treatment compliance (David, 1990), and measurement scales 
were devised for research. This multidimensional model of insight was supported by further 
research (Amador and David, 2004). 
Insight in psychosis is of major clinical relevance given its associations with positive 
outcomes (greater insight, better outcomes) (McEvoy et al., 2004; Lincoln et al., 2007). 
However, insight is also linked with depression (Mintz et al., 2003), i.e., the ‘Insight Paradox’ 
(Lysaker et al., 2007; Belvederi et al., 2015). Indeed, a common assertion among clinicians is 
that insight in psychosis leads to depression and an increased suicide risk in psychosis, 
which is known as the ‘demoralization syndrome’ (Drake et al., 1985; Drake & Cotton, 1986), 
although this remains unproved (Restifo et al., 2009). 
In addition, treatment compliance reduced suicide risk in psychosis (Hawton et al., 
2005; Qin et al., 2006). Hence, insight, which is linked with compliance (McEvoy, 2004), may 
reduce suicide risk via improved compliance. Moreover, recent longitudinal studies either 
find no relationship between insight and suicide risk in FEP (Ayesa-Arriola et al., 2015) and 
some reports even suggest that gaining insight may reduce the risk (Bourgeois et al., 2004; 
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Barrett et al., 2015). From a multidimensional approach to insight, poor compliance was 
reported to increase risk of suicide in schizophrenia (Hawton et al., 2005), which is in line 
with a recent meta-analysis which failed to link treatment compliance with depression 
(Belvederi et al., 2015). 
Our previous systematic review looking at insight and suicide risk in schizophrenia 
and related disorders showed no clear pattern (Lopez-Morinigo et al., 2012). We suggested 
up to four non-mutually exclusive explanations underlying this, namely selection and recall 
biases, which affects cross-sectional studies, the use of uni- vs multidimensional insight 
scales and the extent to which other confounders were considered (Lopez-Morinigo et al., 
2012). Indeed, our previous cross-sectional FEP study (Lopez-Morinigo et al., 2014a) 
demonstrated that suicidal behaviours before first presentation with psychosis, which is the 
strongest predictor of future suicidal acts (Hawton et al., 2005; Pompili et al., 2011), affected 
insight levels at that time (Lopez-Morinigo et al., 2014a). Thus, previous cross-sectional 
studies linking insight with suicidal events were probably missing the more direct 
association between previous and current suicidal behaviour (Lopez-Morinigo et al., 2012). 
We used two large FEP cohorts who were followed-up over prolonged periods to 
investigate the relationships between suicide attempts prior to first contact with services, 
baseline variables, including insight and depression, and future suicidal events. We 
hypothesised that: i) no insight dimension will ‘directly’ increase suicide risk; ii) previous 
suicide attempts and depression will be linked with both baseline insight levels and risk of 
suicidal behaviour; and iii) treatment compliance will ‘directly’ reduce suicide risk. 
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2. METHODS 
2.1. Participants 
We designed an observational prospective cohort study. Data were collected from 
two FEP projects, namely the Aetiology and Ethnicity in Schizophrenia and Other Psychoses 
(AESOP) and the National Institute of Health Research Biomedical Research Centre (NIHR 
BRC) Genetics and Psychosis (GAP). All incident FEP (F10-F29 and F30-F33 ICD-10 codes 
(WHO, 1993)) cases presenting to the South London and Maudsley NHS Foundation Trust 
(London, UK) over 1997-1999 (AESOP) (Morgan et al., 2006) and 2004-2010 (GAP) (Di Forti 
et al., 2009) were invited to take part in the studies, although a small AESOP subsample 
came from Nottingham (UK). Organic psychosis, drug-induced psychosis, IQ less than 50 
and poor fluency of English were exclusion criteria. Diagnoses were made at study 
inception, hence they did not take into account any changes over the follow-up period. 
Participants gave written informed consent and both AESOP and GAP projects received 
ethical approval from the Local Research Ethics Committees. 
2.2. Measures 
2.2.1. Premorbid, sociodemographic and clinical variables 
We collected data on sex, age at admission (GAP) or first contact with services 
(AESOP), education level, living status, employment status and cannabis and alcohol use 
(present/absent). In the AESOP study, the duration of untreated psychosis (DUP) was 
defined as the time from the first psychotic symptom to first contact with services, while the 
Nottingham Onset Schedule (Singh et al., 2005) estimated DUP in the GAP sample, i.e., time 
from first continuous psychotic symptom to treatment onset. 
2.2.2. Information on suicidal behaviour over the follow-up 
Researchers made phone calls and sent letters to patient’s home address and to the 
general practitioner (GP) at 5- (GAP) or 10 years (AESOP) (Morgan et al., 2014) to invite 
them to participate in the follow-up studies. Information on suicidal behaviour - which was 
defined as ‘any potentially self-injurious behaviour for which the person intended to kill 
himself/herself’ (O'Carroll et al., 1996), (i.e., non-suicidal self-injuries were not considered 
(Grandclerc et al., 2016) - was collected from clinical records. Also, AESOP and GAP were 
linked with national mortality data, namely the Office for National Statistics (ONS), which 
records the official cause of death (as ICD-10 codes (WHO, 1993)) in England and Wales.  
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2.2.3. Insight assessment 
Insight was evaluated by the Schedule for Assessment of Insight – Expanded version 
(SAI-E) (Kemp & David, 1997), which takes the form of a semi-structured interview and 
provided scores on David’s model’s insight dimensions - ‘illness recognition’ (IR), 
‘symptoms relabelling’ (SR) and ‘treatment compliance’ (TC) – and total insight scores (TIS) 
(higher score, greater insight). The SAI-E was reported to be easily administered in clinical 
practice (Sanz et al., 1998). The scale author (ASD) provided training for researchers, which 
resulted in good to excellent inter-rater reliability (for TIS intraclass correlation coefficients 
ranged from 0.92 to 0.98 (p<0.001) (Morgan et al., 2010a)). 
2.2.4. Psychopathological symptoms 
In order to measure psychopathological symptoms severity, the Positive and 
Negative Symptoms Scale for Schizophrenia (PANSS, Kay et al., 1987) was used in the GAP 
study. In line with a systematic review of PANSS factor analyses (Wallwork et al., 2012), five 
symptomatic dimensions were considered: positive (range: 4-23), negative (range: 6-27), 
disorganization (range: 3-15), mania (range: 4-16) and depression (range: 3-16), which was 
specifically measured with the Calgary Depression Scale for Schizophrenia (CDSS) 
(Addington et al., 1992), ranging from 0 to 24. The AESOP study evaluated psychopathology 
with the Schedules for Clinical Assessment in Neuropsychiatry (SCAN)’s Item Group 
Checklist (IGC) algorithm (WHO, 1992) and a factor analysis with an overlapping AESOP 
sample had revealed the above five symptomatic dimensions (Demjaha et al., 2009), with 
scores ranging from 0 to: 11 (positive), 8 (negative), 4 (disorganization), 10 (mania) and 6 
(depression).   
2.2.5. Neurocognitive tests 
Two overall measures of general cognition were taken: premorbid IQ, which was 
estimated by the National Adult Reading Test (NART) (Nelson & Willison, 1991), and 
current IQ, which was assessed by the short version of the Wechsler Adult Intelligence Scale 
Revised (WAIS-R) (Wechsler, 1981). The Trail Making Test (time to complete task B minus 
time to complete task A) (TMT B-A) (Reitan, 1958) provided a measure of executive 
functions. 
2.3. Statistical analysis 
First, we investigated differences in demographic and clinical variables, including 
insight scores, between patients with/without suicidal history. Second, we conducted 
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univariable survival analyses to model time from first contact to the first suicidal event 
(irrespective of outcome) or the censoring date, i.e. either the date on which the patient was 
last known to be alive or the end of the follow-up study period, whichever came first. Third, 
those variables associated with first suicide attempt at p≤0.1 were added to multivariable 
Cox Regression (Cox, 1972) models (enter method) to test the effect of insight scores on time 
to suicidal event, whilst controlling for confounders. We calculated Hazards Ratios (HRs) of 
time to event and 95% confidence intervals (CI). We used the Statistical Package for Social 
Science version 25.0 (SPSS Inc., Chicago, IL, USA). 
3. RESULTS 
3.1. Baseline differences between patients with/without previous suicide attempts 
The baseline characteristics of the samples and differences between those 
with/without previous suicide attempts are presented in Table 1 (AESOP, n=181) and Table 
2 (GAP, n=112). 
With regard to insight, in the AESOP cohort (Table 1) those subjects with previous 
suicide attempts scored higher on IR (7.6±1.9 vs. 5.9±3.0, t=3.1, p<0.01), SR (5.5±3.3 vs. 4.7 
±3.7, t=0.82, p=0.41), TC (4.0±1.4 vs. 3.2±1.5, t=1.9, p=0.05) and TIS (17.2±5.0 vs. 13.4±6.7, 
t=2.1, p=0.03) than non-suicide attempters. These results were replicated in the GAP sample, 
in which IR (6.2±2.7 vs. 4.7±3.3, t=2.0, p=0.05), SR (6.4±3.1 vs. 4.5 ±3.4, t=2.2, p=0.03), TC 
(4.3±1.8 vs. 3.6±1.8, t=1.6, p=0.11) and TIS (16.8±6.4 vs. 12.8±7.4, t=2.2, p=0.03) were higher in 
suicide attempters than in non-suicide attempters. 
In terms of psychopathology, only depression in the AESOP cohort was associated 
with previous suicide attempts (scores medians in attempters vs. non-attempters: 5.0 vs. 0.0, 
p<0.01). There were some correlations between psychopathological dimensions and insight 
scores, which are shown in Table S1 (AESOP) and Table S2 (GAP) of the supplementary 
material. In both samples depression strongly correlated with all insight scores except 
compliance in the GAP cohort (r=0.18-0.32) (Table S1 and Table S2). 
No neurocognitive differences between those with/without previous suicide 
attempts emerged from the analyses (Table 1 and Table 2). 
Insert Table 1 here 
Insert Table 2 here 
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3.2. Suicidal events over the follow-up 
In the AESOP cohort, thirty-four subjects (18.7%) attempted suicide either prior to 
first presentation or over the follow-up. Sixteen subjects (8.8%) had previous suicide 
attempts. Twenty-six subjects (14.4%) attempted to end their lives over the follow-up, 
including eight re-attempters (4.4%), i.e., they attempted suicide before and after first 
presentation. We compared the 26 follow-up suicide attempters, including 5 suicide 
completers (hence, a case fatality (CF) of 5/181=2.7%), with 155 non-suicide attempters.  
Thirty-two GAP patients (28.5%) attempted suicide either prior to first contact with 
services or over the study follow-up. Over the follow-up there were 18 suicide attempters 
(16.1%) and 8 of these (7.1%) did so both before and after first contact with services, 
including 3 suicides (CF=3/181=2.7%). We therefore compared 18 follow-up suicide 
attempters and 94 non-suicide attempters. 
In total, over the follow-up periods there were 44 suicide attempters and 80 suicidal 
events. The most common suicide methods were poisoning (n=31) and jumping (n=12), 
which included jumping off a height or in front of a vehicle. See Table S3 (supplementary 
material) for details. 
In terms of attrition, 11 AESOP patients (6.0%) and 9 GAP subjects (8.0%) were lost to 
follow-up. We compared these subjects with those who had follow-up data available. There 
were no differences in age, gender, education level, marital status, living status, employment 
status, history of previous suicide attempts, diagnoses, drugs/alcohol use, DUP, 
psychopathological, neurocognitive or insight variables, although in the AESOP cohort the 
proprotion of Black people was higher in those who could not be followed-up (69.2%) in 
comparison with follow-up patients (31.2%) (X2=7.72, p=0.005) and in the GAP cohort those 
who were lost to follow-up had higher scores on the PANSS positive dimension (p=0.02) 
than follow-up patients. Data available upon request.    
3.3. Risk factors for suicidal behaviour over the follow-up 
Univariable analyses of demographic, clinical, psychopathological, neurocognitive 
and insight variables are shown in Table 3 and Table 4. 
Insert Table 3 here 
Insert Table 4 here 
9 
 
In the AESOP cohort, previous suicide attempts (HR=2.92, 95%CI=0.96-8.86, p=0.06), 
executive functions (TMT B-A) (HR=1.01, 95%CI=1.00-1.02, p=0.01), depression (HR=1.57, 
95%CI=1.30-1.89, p<0.01), TC (HR=1.30, 95%CI=0.99-1.71, p=0.06) and TIS (HR=1.06, 
95%=CI 0.99-1.13, p=0.08) - were linked with time to first suicidal event and were added to a 
Cox regression model. Depression (HR=1.55, 95%CI=1.22-1.97, p<0.01) and previous suicide 
attempts (HR=2.75, 95%CI=0.90-8.52, p=0.07) remained associated with time to first suicidal 
event (Table 5). 
In the GAP study, age at first presentation (HR=2.92, 95%CI=0.96-8.86, p=0.06), 
living alone (HR=3.57, 95%CI=1.32-9.65, p=0.01), previous suicide attempts (HR=3.95, 95% 
CI=1.55-10.1, p<0.01), premorbid IQ (HR=0.96, 95%CI=0.91-1.01, p=0.09), depression 
(HR=1.09, 95%CI=0.99-1.08, p=0.08), TC (HR=1.06, 95%CI=1.01-1.83, p=0.04) and TIS 
(HR=1.06, 95%CI=0.99-1.14, p=0.08) were associated with time to first suicidal event. Age at 
first presentation, living status, previous suicide attempts, full premorbid IQ, depression, TC 
and TIS were entered into the Cox regression model. Previous suicide attempts (HR=5.17, 
95%CI=1.32-20.29, p=0.02) and depression (HR=1.16, 95%CI=1.00-1.35, p=0.04) remained 
associated with time to first suicidal event (Table 5).  
Insert Table 5 here 
These results were replicated when removing depression from the analyses. In 
particular, in the AESOP cohort previous suicide attempts (HR=4.67, 95%CI=1.65-13.28, 
p=0.04) and TMT-B-A (HR=1.01, 95%CI=1.00-1.01, p=0.03) were associated with time to first 
suicidal event, while insight scores failed to replicate such an association. In the GAP cohort, 
however, living alone (HR=4.50, 95%CI=1.31-15.50, p=0.02) and previous suicide attempts 
(HR=5.35, 95%CI=1.56-18.32, p<0.01) were linked with time to suicidal behaviour. Similarly, 
when not including those individuals with previous suicide attempts in the analyses, insight 
dimensions were not associated with suicidal behaviour. Specifically, in the AESOP cohort 
only depression (HR=2.45, 95%CI=1.05-5.74), p=0.04) was associated with time to first 
suicidal act, whilst in the GAP sample these were not significant (p<0.05) predictors of 
suicidal behaviour.      
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4. DISCUSSION 
4.1. Main findings 
In light of our results, we can draw four main conclusions. First, previous suicide 
attempts and depression were associated with an increased risk of suicidal behaviour in 
early psychosis. Second, consistent with the first hypothesis, no insight dimension was 
‘directly’ associated with an increased risk of suicidal behaviours, which was predicted by 
both depression and previous suicide attempts, both of which were linked with baseline 
insight levels, hence in line with hypothesis ii. In other words, we found no evidence to 
support the commonly held theory of association between insight and suicide risk in 
psychosis, which appears to be explained by two confounders, namely, previous suicide 
attempts and depression. Thirdly, contrary to hypothesis iii, treatment compliance increased 
risk of suicidal behaviour, although such an association did not remain significant after 
controlling for confounders. Fourth, our previous finding from the GAP cohort (Lopez-
Morinigo et al., 2014a) that suicidal antecedents prior to first presentation influenced insight 
levels at that point was replicated in the AESOP cohort, consistent with a previous AESOP 
study with an overlapping sample (Harvey et al., 2008). 
4.2. Insight dimensions and risk of suicidal behaviour 
Interestingly, insight scores were not associated with suicide risk in the multivariable 
regression models, which was consistent with our hypotheses, our previous literature 
review (Lopez-Morinigo et al., 2012) and recent studies (Yan et al., 2013; Pijnenborg et al., 
2013; Barrett et al., 2015). Hence, other confounders appear to play a role in the relationship 
between insight and suicide risk in psychosis, although many clinicians remain concerned 
about improving insight in early onset psychosis patients. 
Gaining awareness of having a psychotic illness could be thought to lead to more 
severe depressive symptoms, hence increasing the risk of suicide, i.e., the so-called 
‘demoralization syndrome’ (Drake et al., 1985; Drake and Cotton, 1986; Amador et al., 1996; 
Restifo et al., 2009). However, the ‘depressive realism model’ may explain why a more 
depressed patient, who is biased by the cognitive distortions associated with depression (or 
less prone to ‘normal’ optimistic biases), tends to think more pessimistically about 
him/herself (Ghaemi and Rosenquist, 2004), hence being scored higher at the time of the 
insight assessment. In keeping with this, it could be argued that those with higher levels of 
insight may be more likely to recall previous suicidal events. This is why in our previous 
systematic review cited in the introduction (Lopez-Morinigo et al., 2012) we postulated that 
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recall bias may contribute to the conflicting findings regarding the association between 
insight and suicide risk in psychosis. Furthermore, although almost half of suicide 
completers had communicated suicide intent to some extent, it remains unclear what 
predicts suicide risk in relation to suicide communication, including diagnosis (for instance, 
psychosis) (Pompili et al., 2016). In order to solve this ‘chicken and egg’ dilemma, 
longitudinal intervention studies are needed; for example, if an insight improving 
intervention was demonstrated not to increase suicidality, this would go against the 
demoralization syndrome account. This is indeed what intervention studies show 
(Bourgeois et al., 2004; Pijnenborg et al., 2013; Barretet al., 2015). Specifically, based on the 
relationship between lack of insight and metacognitive deficits in schizophrenia and related 
disorders, metacognitive training (MCT) has been postulated to improve insight, which may 
also decrease suicide risk, although this remains to be established (Lysaker et al., 2018). On 
the other hand, some insight improving interventions may increase suicide risk. Hence, 
further research in this area is warranted.     
However, treatment compliance increased risk of suicidal behaviour in our both FEP 
cohorts, which goes against previous reviews (Hawton et al., 2005) and our expectations. 
From a conceptual point of view, it should be noted that ‘awareness’ of the need for 
treatment is not the same as ‘acceptance’ (Morgan and David, 2010b), which implies some 
degree of ‘subordination’, a well-known contributing factor for depression in psychosis 
(Upthegrove et al., 2016). Also, it could be speculated that the extent to which treatment is 
successful (in someone who is aware of the need for treatment) may moderate this 
association, which needs further longitudinal studies. Specifically, our study could not test 
whether longer-term ‘treatment compliance’ was linked with greater (or lower) suicide risk.   
4.3. Predictors of suicidal behaviour over the follow-up 
Younger age at first presentation, living alone, previous suicidal history, executive 
dysfunction and depression were found to be the four main predictors of suicidal behaviour, 
in addition to awareness of the need for treatment. However, only previous suicide attempts 
and depression remained ‘significant’ (at p<0.05) in the final multivariable models. Given 
their association with insight scores at baseline, previous suicide attempts and depression 
appear to act as confounders in the relationship between insight and future suicidal 
behaviours, as discussed below. 
Suicide risk in psychosis has been consistently found to be higher in young patients 
(e.g. Palmer et al., 2005; Limosin et al., 2007; Osborn et al., 2008; Alaräisänen et al., 2009; 
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Dutta et al., 2010; Barrett et al., 2010a; Barrett et al., 2010b), which was replicated by our 
results. Hence, early psychosis patients require close monitoring (Popovic et al., 2014; 
NCISH, 2017). However, it remains unclear whether early intervention services are 
associated with a decreased suicide risk. Specifically, the initial protective effect seems to 
disappear once the early intervention period ends (Bertelsen et al., 2008; Melle et al., 2006; 
Harris et al., 2008), although extending the treatment period reduced suicide rates in Hong 
Kong when compared with standard care (Chan et al., 2018). 
Living alone was linked with an increased suicide risk both in schizophrenia 
(Hawton et al., 2005) and FEP (Challis et al., 2013). Of concern, most patients with psychosis 
who reside in our catchment area live alone (Kirkbride et al., 2006). However, to our 
knowledge no previous studies have tested whether sheltered or supported accommodation 
in early psychosis may reduce suicide risk.  
Overall, conflicting findings have been reported regarding the relationship between 
neurocognition and suicide risk in psychosis (Andersson et al., 2008, Webb et al., 2011; 
Potkin et al., 2003; Barrett et al., 2011; Hor & Taylor, 2010), although cognitive impairment 
may behave as a protective factor in schizophrenia (De Hert et al., 2001). Hence, cohort 
studies, including comprehensive neurocognitive assessments over time, are warranted in 
this area. 
4.4. Previous suicide attempts and depression were related to baseline insight and 
predicted future suicidal behaviours 
In our previous cross-sectional study with the GAP sample (Lopez-Morinigo et al., 
2014a) we demonstrated that suicide attempts preceding first contact with services on 
affected insight levels at that time, which was replicated by the AESOP sample presented in 
this study. In addition, previous suicide attempts was associated with an increased risk of 
future suicidal events in both cohorts, which was in line with previous literature (e.g. De 
Hert et al., 2001; Hawton et al., 2005; Dutta et al., 2010; Bakst et al., 2010; Pompili et al., 2011) 
including a 2013 meta-analysis (Challis et al., 2013). Hence, previous suicide attempts (prior 
to first contact) influenced insight levels at that point. Also, previous suicide attempts, but 
not baseline insight scores, were associated with suicidal behaviours in the multivariable 
models, with ‘significant’ (at p<0.05) HRs ranging from 2.75 (AESOP) to 5.31 (GAP), hence a 
strong association. In other words, previous suicide attempts seem to explain in part the 
apparent association between insight and suicidal behaviour in psychosis, which is 
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consistent with a previous cross-sectional study (Massons et al., 2017). Nevertheless, up to 
42% of suicide completers with schizophrenia spectrum disorder have no previous suicide 
attempts (LopezMorinigo et al., 2014b; Lopez-Morinigo et al., 2016). 
In addition, depression emerged as the main therapeutic target to prevent suicidality 
in both FEP cohorts, which was in full agreement with previous literature (Altamura et al., 
2003; Bertelsen et al., 2007; Flanagan and Compton, 2012; Harvey et al., 2008; Kontaxakis et 
al., 2004; Barrett et al., 2010a; Barrett et al., 2010b). Depression was associated with all insight 
dimensions in both cohorts except compliance in the GAP sample (Lopez-Morinigo et al., 
2014a), which is in full agreement with previous literature (Mintz et al., 2003; Belvederi et al., 
2015). Hence, depression was associated with insight, and depression, but not insight, 
remained associated with suicidal behaviours in the multivariable regression models, with 
‘significant’ (at p<0.05) HRs ranging from 1.16 (GAP) to 1.55 (AESOP), which was still a 
strong association since depression was a continuous variable. Hence, depression emerged 
as the second main confounder explaining the apparent relationship between insight and 
suicidality in psychosis, consistent with two previous cross-sectional studies (Massons et al., 
2017; Roux et al., 2018). 
Interestingly, depression was found to be a significant risk factor for suicide, even 
after adjusting for confounders, in three studies (Bakst et al., 2009; Barrett et al., 2010; Restifo 
et al., 2009) included in our systematic review (Lopez-Morinigo et al., 2012). These studies 
had failed to link insight with suicidality, which was predicted by hopelessness (Kim et al., 
2003; Bourgeois et al., 2004; Acosta et al., 2009), consistent with a previous meta-analysis 
(Hawton et al., 2005). Hopelessness, i.e., ‘the cognitive element of negative expectations’ 
(Minkoff et al., 1973), was reported to increase suicide risk in outpatients (Beck et al., 1990), 
thus becoming the main clinical target for suicide risk management in schizophrenia 
(Pompili et al., 2004). 
However, ‘depression’ in psychosis could be viewed as a symptomatic dimension 
(Peralta et al., 2013) or a psychological reaction to such a stigmatising diagnosis (Drake & 
Cotton, 1986). A 1-year follow-up FEP study reported depression in the acute stage to be 
associated with hearing malevolent voices, use of safety behaviour and subordination to 
persecutors, while loss, shame, low level continuing positive symptoms and longer duration 
of untreated psychosis predicted post-psychotic depression (Upthegrove et al., 2014). 
Also, prodromal depression was linked with later suicidality and depression in FEP 
(Upthegrove et al., 2010), which goes against the ‘demoralization syndrome’ (Drake and 
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Cotton, 1986), i.e., depression in psychosis appears to have trait-like properties (Upthegrove 
et al., 2010). However, depression in schizophrenia was demonstrated to have both state- 
and trait-like properties, both of which were different from negative symptoms (Chiappelli 
et al., 2014). Indeed, distinguishing negative symptoms from depression remains 
challenging in the clinical setting, which has relevant clinical implications since overall, 
depression is a major contributor for suicide in schizophrenia (Hawton et al., 2005) and FEP 
(Pompili et al., 2011; Challis et al., 2013; McGinty et al., 2017). However, current guidelines 
in the treatment of depression in patients with schizophrenia are limited (Gregory et al., 
2017). 
In summary, three points should be carefully considered in future studies addressing 
this issue. First, previous suicide attempts behave as the strongest predictor of future 
suicidal events both in schizophrenia (e.g. Hawton et al., 2005) and FEP (Challis et al., 2013) 
and previous suicide attempts influence insight levels at first presentations with psychosis 
(Lopez-Morinigo et al., 2014a). Second, depression in psychosis, which has both state- and 
trait-like properties (Chiappelli et al., 2014) and can precede the onset of psychotic 
symptoms, is linked with previous and future suicidal acts and insight levels at the time of 
assessment (i.e. at first contact with services). Therefore, prospective intervention studies 
such as randomized clinical trials comparing those receiving an intervention aimed at 
improving both insight and depression with those without such treatment may shed some 
light on this issue; for instance, by comparing those receiving MCT (Lysaker et al., 2018) vs. 
those with standard care. In particular, these studies should carefully assess depressive 
symptom severity, insight levels and suicide risk over time and from a statistical point of 
view mediation analyses should be performed.     
4.5. Strengths and limitations 
This is the first longitudinal study testing the role of multiple insight dimensions in 
suicidal behaviour in early psychosis. In addition, two large FEP cohorts were followed-up 
over prolonged periods. All incident FEP cases presenting to NHS hospitals in the 
catchment areas were approached and invited to take part in the studies. Since most 
psychosis patients in the UK receive NHS-funded mental healthcare, the samples are likely 
to be representative. A number of demographic, clinical, psychopathological, insight-related 
and neurocognitive variables were comprehensively assessed using validated instruments. 
Also, the low attrition rates (6-8%), with no relevant differences between those who were 
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lost to follow-up and those who were not (see section 3.2. above for details), are unlikely to 
have affected the findings significantly. 
However, this study has several limitations. First, the samples may have been 
underpowered to detect some between-groups differences. This was likely to apply to those 
who took their lives (in total, only 8 subjects in this study). As a result, we could not analyse 
the relationship between lethality and suicide methods (among other variables) in FEP 
patients. Second, other variables such as premorbid personality (Lysaker et al., 1999; 
Campos et al., 2011; Cuesta et al., 2011; Ritsner & Blumenkrantz, 2010), premorbid 
adjustment (Keshavan et al., 2004) and neuroanatomical correlates (Morgan et al., 2010a; 
David et al., 2012), which were not evaluated in this study, may contribute to insight. Third, 
researchers were not blind to other assessments which might affect the insight scores 
(Campos et al., 2011). Fourth, we could not investigate insight changes over time (Wiffen et 
al., 2010; Campos et al., 2011; Cuesta et al., 2011; AyesaArriola et al., 2014), which were only 
evaluated in a small AESOP subsample, in relation to suicide risk. Fifth, diagnoses were 
made at the study inception, which may have resulted in the inclusion of patients who may 
have transitioned to a non-psychotic diagnosis over the follow-up, although this is unlikely 
given the diagnosis stability of psychotic disorders (Heslin et al., 2015). In addition, 
diagnoses and other variables such as treatment compliance and socio-cultural issues, which 
were not evaluated in this study, may have affected the relationship between insight and 
suicide risk (Belvederi Murri & Amore, 2018).  
4.6. Final remarks 
We followed-up two large FEP cohorts over prolonged periods to investigate the role 
of insight in suicide risk in early psychosis; however, we found no evidence of a ‘direct’ 
association of insight with suicidal behaviour. Specifically, previous suicide attempts and 
depression emerged as the main predictors of suicidal behaviour and they were linked with 
baseline insight levels. However, insight scores were not associated with suicidal behaviour 
in the multivariable regression models, i.e., after controlling for confounders. Also, these 
findings were replicated when removing depression from the analyses and when those 
subjects with previous suicide attempts were not included in the models, which provides 
further support for the confounding role of both previous suicide attempts and depression 
in the relationship between insight and suicidality in psychosis. This seems to explain the 
clinical notion that insight increases risk of suicidal behaviour in psychosis, in line with two 
previous cross-sectional studies (Massons et al., 2017; Roux et al., 2018). Future longitudinal 
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studies are warranted to test whether insight improving interventions decrease suicide risk 
in psychosis. 
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Table 1. Demographic and clinical characteristics of the AESOP sample 
 Total sample 
N=181 
With previous 
SA 
n = 16 (9.9%) 
Without previous 
SA 
n = 146 (90.1%) 
Statistic p-value 
Age at first contact, years 30.5 ± 11.3 31.4 ± 11.5 31.4 ± 11.2 t=-0.0 0.97 
Gender, males 101 (55.8) 8 (50.0) 78 (53.4) Χ2=0.1 0.79 
Level of education      
    No qualifications 51 (31.5) 9 (56.2) 42 (28.8) Χ2=5.0 0.02 
    ≥GCSE 111 (68.5) 7 (43.7) 104 (71.2)   
Unmarried 111 (67.7) 9 (56.2) 99 (67.8) Χ2=0.8 0.35 
Living alone 52 (31.0) 5 (39.0) 45 (28.9) Χ2=0.4 0.53 
Unemployed 78 (44.6) 8 (50.0) 61 (41.8)   
Ethnicity    Χ2=0.2 0.63 
White 101 (55.8) 10 (62.5) 82 (56.2) Χ2=1.4 0.23 
Black 61 (33.7) 3 (18.7) 49 (33.6) Χ2=1.0 0.30 
Other 19 (10.5) 3 (18.7) 15 (10.3)   
DUP: days, median 49.5 51 47 U 0.06 
Diagnosis (ICD-10)      
    Schizophrenia spectrum 118 (65.2) 10 (62.5) 93 (63.7) Χ2=0.0 0.92 
    Mania with psychosis 31 (17.1) 0 (0) 30 (20.5) Χ2=4.0 0.04 
    Psychotic depression 32 (17.7) 6 (37.5) 23 (15.7) Χ2=4.6 0.03 
Drugs use 103 (58.9) 7 (46.7) 83 (58.4) Χ2=0.8 0.38 
Alcohol use 152 (84.4) 14 (87.5) 124 (85.5) Χ2=0.0 0.83 
Insight scores      
    Recognition 6.0 ± 3.0 7.6 ± 1.9 5.9 ± 3.0 t=3.1 <0.01 
    Relabelling 4.7 ± 3.6 5.5 ± 3.3 4.7 ± 3.7 t=0.82 0.41 
    Compliance 3.2 ± 1.5 4.0 ± 1.4 3.2 ± 1.5 t=1.9 0.05 
    Total Insight 13.6 ± 6.6 17.2 ± 5.0 13.4 ± 6.7 t=2.1 0.03 
Psychopathology      
    Positive  4.0 4.5 4.0 U 0.26 
    Negative  1.0 2.0 0.0 U 0.05 
    Disorganization 0.0 0.0 0.0 U 0.51 
    Mania 1.0 0.0 1.0 U 0.07 
    Depression 0.0 5.0 0.0 U <0.01 
Neurocognition      
    Full Premorbid IQ 97.2 ± 14.6 97.6 ± 17.5 98.3 ± 14.2 t=-0.2 0.86 
    Current IQ 89.6 ± 16.0 89.0 ± 16.0 91.0 ± 16.5 t=-0.4 0.69 
    TMT-A (seconds) 47.2 ± 27.0 50.0 ± 24.0 45.1 ± 24.8 t=0.6 0.53 
    TMT-B (seconds) 107.3 ± 62.5 127.2 ± 77.3 102.7 ± 60.3 t=1.2 0.21 
    TMT-B-A (seconds) 60.9 ± 46.4 77.2 ± 68.9 58.6 ± 45.4 t=0.9 0.40 
AESOP: Aetiology and Ethnicity in Schizophrenia and Other Psychoses study. SA: suicide 
attempts. GCSE: General Certificate of Secondary Education. DUP: Duration of untreated 
psychosis. IQ: Intelligence Quotient. TMT: Trail Making Test (Reitan, 1958) 
 
Table(s)
Table 2. Demographic and clinical characteristics of the GAP sample 
 
 
Total sample 
N=112 
With previous 
SA 
n = 22 (19.6%) 
Without previous 
SA 
n = 90 (80.3%) 
Statistic p-value 
Age at first contact, years  29.4 ± 9.2 27.8 ± 5.8 29.8 ± 5.8 t = -1.2 0.21 
Gender, males 73 (65.2) 13 (59.0) 60 (66.6) Χ2  = 0.5 0.50 
Level of education      
    No qualifications 18 (66.4) 4 (18.2) 14 (15.9) Χ2  = 0.1 0.79 
    GCSE 23 (20.9) 5 (22.7) 18 (20.4) Χ2  = 0.1 0.81 
    Further 42 (38.2) 7 (31.8) 35 (39.8) Χ2  = 0.5 0.50 
    University 27 (24.5) 6 (27.3) 21 (23.8) Χ2  = 0.1 0.74 
Unmarried 84 (75.7) 16 (72.7) 68 (76.4) Χ2  = 0.1 0.72 
Living alone 40 (36.0) 11 (50.0) 29 (32.5) Χ2  = 2.3 0.13 
Unemployed 69 (62.7) 10 (45.4) 59 (67.0) Χ2  = 3.5 0.06 
Ethnicity      
    White 29 (26.1) 9 (40.9) 20 (22.5) Χ2  = 3.1 0.08 
    Black 49 (44.1) 6 (27.2) 43 (48.3) Χ2  = 3.2 0.07 
    Other 33 (29.7) 7 (31.8) 26 (29.2) Χ2  = 0.1 0.81 
DUP: days, median 42 36 60 U 0.85 
Diagnosis (ICD-10)      
    Schizophrenia spectrum 86 (77.5) 15 (71.4) 71 (78.9) Χ2  = 0.5 0.46 
    Mania with psychosis 16 (14.4) 3 (14.3) 13 (14.4) Χ2  = 0.0 0.98 
    Psychotic depression 9 (8.1) 3 (14.3) 6 (6.6) Χ2  = 1.3 0.25 
Cannabis use 81 (72.3) 18 (81.8) 63 (70.0) Χ2  = 1.2 0.27 
Alcohol use 68 (75.6) 14 (87.5) 54 (72.9) Χ2  = 1.5 0.22 
Insight scores      
    Recognition 4.9 ± 3.3 6.2 ± 2.7 4.7 ± 3.3 t = 2.0 p=0.05 
    Relabelling 4.9 ± 3.4 6.4 ± 3.1 4.5 ± 3.4 t = 2.2 p=0.03 
    Compliance 3.7 ± 1.8 4.3 ± 1.8 3.6 ± 1.8 t = 1.6 p=0.11 
    Total Insight 13.6 ± 7.3 16.8 ± 6.4 12.8 ± 7.4 t = 2.2 p=0.03 
Psychopathology      
    Positive  9.2 ± 4.4 8.7 ± 4.3 9.3 ± 4.4 U 0.47 
    Negative  11.9 ± 6.1 12.0 ± 5.6 11.9 ± 6.2 U 0.95 
    Disorganization 6.4 ± 2.7 5.5 ± 2.3 6.6 ± 2.8 U 0.37 
    Mania 5.4 ± 2.2 4.8 ± 1.1 5.5 ± 2.4 U 0.98 
    Depression 4.8 ± 4.7 6.0 ± 4.6 4.5 ± 4.8 t = 1.2 0.24 
Neurocognition      
    Premorbid Full IQ 90.5 ± 10.6 91.9 ± 9.6 90.1 ± 10.8 t = 0.6 0.52 
    Current IQ 88.4 ± 25.3 93.9 ± 14.1 87.1 ± 27.3 t = 1.0 0.31 
    TMT-A (seconds) 47.0 ± 20.9 41.6 ± 17.1 48.3 ± 21.7 t = -1.2 0.23 
    TMT-B (seconds) 119.5 ± 74.0 97.7 ± 56.1 125.2 ± 77.4 t = -1.4 0.16 
    TMT-B-A (seconds) 71.8 ± 62.4 60.3 ± 49.6 74.8 ± 65.4 t = -0.8 0.38 
GAP: Genetics and Psychosis study. SA: suicide attempts. GCSE: General Certificate of 
Secondary Education. DUP: Duration of untreated psychosis. IQ: Intelligence Quotient. TMT: 
Trail Making Test (Reitan, 1958) 
 
Table(s)
Table 3. Univariable analysis: Kaplan-Meier log-rank tests of equality of survival distributions for nominal variables 
 AESOP GAP 
Risk factor Events 
expected 
Events 
observed 
Log-rank test 
(X2) 
p-value Events 
expected 
Events 
observed 
Log-rank test 
(X2) 
p-value 
Gender Male 12.8 11 0.75 0.39 11.7 12 0.03 0.86 
 Female 11.1 13   6.3 6   
Age at first contact <28 years 11.7 12 0.00 0.95 9.8 14 4.01 0.04 
 >28 years 12.3 12   8.2 4   
Education level No qualifications 2.8 2 0.22 0.64 2.8 4 1.58 0.66 
 GCSE or higher 6.2 7   14.2 13   
Marital status Unmarried 6.0 5 0.67 0.41 12.9 14 0.49 0.48 
 Married 2.3 4   4.1 3   
Living status Alone 7.6 10 1.25 0.26 6.1 11 4.46 <0.01 
 Not alone 16.4 14   10.9 6   
Employment status Unemployed 10.4 8 1.01 0.32 10.7 9 1.01 0.32 
 Employed 13.6 16   6.3 8   
Ethnicity White 13.4 16 1.84 0.40 4.4 7 2.34 0.31 
 Black 7.9 5   7.5 6   
 Other 2.6 3   5.0 4   
Previous SA Absent  21.6 16 23.11 <0.01 14.5 10 10.06 <0.01 
 Present 2.4 8   3.5 8   
DUP Short 12.0 (<49d) 11 0.22 0.64 8.6 (<42d) 10 0.72 0.40 
 Long 12.0 (>49d) 13   8.4 (>42d) 7   
Diagnosis Schizophrenia 15.2 16 0.76 0.68 13.9 17 3.24 0.19 
 Mania 4.5 3   2.5 1   
 Depression 4.3 5   1.4 0   
Drugs use Absent 10.4 9 0.38 0.54 4.9 3 0.98 0.32 
 Present 13.6 15   13.0 15   
Alcohol use Absent 3.6 0 4.49 0.03 3.2 2 0.97 0.32 
 Present 20.4 24   9.8 13   
AESOP: Aetiology and Ethnicity in Schizophrenia and Other Psychoses study. GAP: Genetics and psychosis study. SA: suicide attempts. GCSE: General Certificate of Secondary Education. 
DUP: Duration of untreated psychosis. d: days 
Table(s)
Table 4. Univariable Cox regression analyses for continuous variables 
 AESOP GAP 
Risk factor HR 95% CI p-value HR 95% CI p-value 
Neurocognition       
    Full premorbid IQ 1.02 0.99 - 1.06 0.21 0.95 0.91 - 1.00 0.09 
    TMT-B-A 1.01 1.00 – 1.02 0.01 0.83 0.99 – 1.01 0.83 
Psychopathology       
    Positive 1.08 0.93 – 1.24 0.33 1.02 0.91 – 1.15 0.70 
    Negative 0.93 0.74 – 1.17 0.53 1.06 0.99 – 1.14 0.10 
    Disorganization 0.84 0.51 – 1.38 0.48 0.98 0.82 – 1.17 0.83 
    Mania 0.96 0.80 – 1.16 0.68 0.83 0.59 – 1.16 0.20 
    Depression 1.57 1.30 – 1.89 <0.01 1.09 0.99 – 1.18 0.08 
Insight       
    Recognition 1.14 0.98 – 1.34 0.09 1.09 0.94 – 1.26 0.24 
    Relabeling 1.06 0.96 - 1.18 0.25 1.10 0.95 - 1.26 0.19 
    Compliance 1.30 0.99 – 1.71 0.06 1.36 1.01 – 1.83 0.04 
    Total insight 1.06 0.99 – 1.13 0.08 1.06 0.99 – 1.14 0.08 
 AESOP: Aetiology and Ethnicity in Schizophrenia and Other Psychoses study. GAP: Genetics and Psychosis study. 
SA: suicide attempts. DUP: Duration of untreated psychosis. IQ: Intelligence Quotient. TMT: Trail Making Test (Reitan, 1958) 
 
Table(s)
 Table 5. Multivariable Cox Regression models in the AESOP and GAP cohorts 
AESOP GAP 
Risk factor  HR 95% CI p-value Risk factor  HR 95% CI p-value 
Previous SA Present 2.75 0.90 – 8.52 0.07 Age at first contact <28 years 5.31 0.82 – 34.16 0.08 
 Absent 1.00    >28 years 1.00   
TMT B-A  1.00 0.99 – 1.01 0.13 Living status Alone 4.56 0.98 – 21.12 0.05 
Depression  1.55 1.22 – 1.97 <0.01  Not alone 1.00   
Recognition  1.02 0.69 – 1.50 0.92 Previous SA Present 5.17 1.32 – 20.29 0.02 
Compliance  1.08 0.70 – 1.67 0.73  Absent 1.00   
Total insight  1.04 0.87 – 1.24 0.65 Full Premorbid IQ  0.95 0.87 – 1.03 0.24 
     Depression  1.16 1.00 – 1.35 0.04 
     Compliance  1.41 0.83 – 2.38 0.20 
     Total Insight  1.06 0.90 – 1.24 0.50 
AESOP: Aetiology and Ethnicity in Schizophrenia and Other Psychoses study. GAP: Genetics and Psychosis study. SA: suicide attempts. 
IQ: Intelligence Quotient. TMT: Trail Making Test (Reitan, 1958) 
 
Table(s)
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